Excision BioTherapeutics Inc.
Philadelphia, PA · CIK 0001847173 · Biotech · Private
None identifiable - text describes a music artist/dubstep producer
excisionbio.com →- Grants
- $435K
- 2 awards
- Sector median: 1
- Raised
- $71M
- 2 Form D · Mar 2021
- 67 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 0 granted · 40 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Towards The Therapeutic Implementation of New CRISPR-Cas Systems | $217,484 | |
| Federal grant | Department of Health and Human Services · Phase I · Towards The Therapeutic Implementation of New CRISPR-Cas Systems | $217,484 | |
| Private capital raised | Form D · SEC | $60,738,974 | |
| Private capital raised | Form D · SEC | $10,500,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2167 | Immunovant | — | $450M |
| 2168 | Ocugen | — | $126M |
| 2169 | VISIONARY PHARMACEUTICALS, INC. | — | — |
| 2170 | Excision BioTherapeutics Inc. | — | $71M |
| 2171 | Context Therapeutics | — | $100M |
| 2172 | QT Holdings Corp. | — | $3.8M |
| 2173 | LOKI THERAPEUTICS, INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Vasudev BaileyDirector
- William CarsonDirector
- Daniel DornbuschDirector · Executive Officer
- Ashok KrishnamurthiDirector
Patents
- Guide Nucleic Acid Identification And Methods Of Useapplication
- Compositions And Methods Of Treatment For Lytic And Lysogenic Virusesapplication
- Compositions And Methods For Excision With Single Grnaapplication
- Compositions And Methods Of Treatment For Lytic And Lysogenic Virusesapplication
- Metabalomics And Viral Diagnostics Suiteapplication
- Hiv Clinical Planapplication
- Visualizing Viral Reservoirs And Dissemination In Vivoapplication
- Lentivirus And Non-integrating Lentivirus As Viral Vector To Deliver Crispr Therapeuticapplication
- CRISPRsapplication
- Hepatitis B Virus Guide Nucleic Acid Compositions And Methods Of Useapplication
- Guide Nucleic Acid Identification And Methods Of Useapplication
- Hepatitis B Virus Guide Nucleic Acid Compositions And Methods Of Useapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.